Figures computed from official regulatory filings — .
Analysttarget 3 USD (+186%)
Ownershipinsiders 0% · institutions 2.58% · short 8.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for iSpecimen Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
11 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Dhaliwal Avtar | AwardD (derivative) | $860.2 | SEC | ||
| Field Katharyn |
| AwardD (derivative) |
| $860.2 |
| SEC |
| Paolone Richard | AwardD (derivative) | $860.2 | SEC |
| Gullans Steven R. Ph.D.track record | AwardD (derivative) | $5.3K | SEC |
| Ross Andrew L.track record | AwardD (derivative) | $5.3K | SEC |
| Graham Elizabeth Ames | AwardD (derivative) | $2.3K | SEC |
| Brooks John L | AwardD (derivative) | $5.3K | SEC |
| Mock Theresa L | AwardD (derivative) | $5.3K | SEC |
| Bielak Benjamin | Buy | $13K | conv 73First in 12mo | SEC |
| Curley Tracy | Buy | $5.5K | conv 73First in 12mo | SEC |
| Ross Andrew L.track record | Award | n/a (No price was disclosed in the filing) | SEC |
| Brooks John L | Award | n/a (No price was disclosed in the filing) | SEC |
| Gullans Steven R. Ph.D.track record | Award | n/a (No price was disclosed in the filing) | SEC |
| Basile Joseph J. | Award | n/a (No price was disclosed in the filing) | SEC |
| Mullan Jill | Award | n/a (No price was disclosed in the filing) | SEC |
| Ianelli Christopher | Award | n/a (No price was disclosed in the filing) | SEC |
| Brooks John L | Award | n/a (No price was disclosed in the filing) | SEC |
| Lawrence Margaret H. | Award | n/a (No price was disclosed in the filing) | SEC |
| Ross Andrew L.track record | Award | n/a (No price was disclosed in the filing) | SEC |
| Gullans Steven R. Ph.D.track record | Award | n/a (No price was disclosed in the filing) | SEC |
| Scholl George H. | Award | n/a (No price was disclosed in the filing) | SEC |
| Ianelli Christopher | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mullan Jill | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mullan Jill | AwardD (derivative) | $14.1K | SEC |
| Mullan Jill | Exercise | $66.6K | Unusual size | SEC |